Gene editing in mouse brains fixes autism-like behaviors caused by genetic mutations
This week brought remarkable progress in using CRISPR gene editing to treat diseases once thought untreatableโfrom fixing genetic brain disorders in living mice to engineering better tools for precise DNA editing.
๐ง Gene editing reverses autism-like behaviors in mice with brain disorder
Researchers used a new gene editing tool called TeABE to fix a genetic mutation (CHD3 p.R1025W) that causes Snijders Blok-Campeau syndrome, a disorder marked by intellectual disability and autism-like behaviors
The treatment was delivered directly to mouse brains using engineered viruses and successfully corrected the mutation across multiple brain regions, restoring normal protein levels
Treated mice showed significant improvements in social communication, learning, and motor coordination compared to untreated mice with the same genetic mutation
Why it matters: This demonstrates that precise gene editing can reverse complex behavioral and cognitive symptoms even after birth, offering hope for treating genetic neurodevelopmental disorders in humans.
Key Findings
๐ง New compact CRISPR tool dramatically expands genome editing targets
Engineers created evoCas12f, a smaller gene editing tool that recognizes 16 times more DNA target sites than previous versions by expanding from TTTR sequences to NTNR/NYTR patterns
The improved tool achieved up to 91% editing efficiency and successfully created genetic changes in newborn mice, even at previously inaccessible DNA sites
The compact size makes it suitable for gene therapy delivery methods that have strict size limitations, like certain viral vectors
๐ Gene editing prevents heart failure by blocking a key protein switch
Scientists used CRISPR to edit the PKCฮฑ gene, preventing a critical protein modification (T497 phosphorylation) that normally triggers heart failure pathways
Mice with the edited gene were protected from heart failure symptoms, cardiac enlargement, and lung congestion after surgical stress that normally causes heart failure
The same editing approach worked in human heart cells grown from stem cells, suggesting potential clinical applications
๐งช Simple nutrient boost improves gene editing accuracy 4-fold
Adding thymidine (a DNA building block) to cell cultures increased the efficiency of C-to-A gene editing by up to 4-fold and improved editing precision by 2.7-fold
The supplement works by elevating cellular levels of dTTP, which helps DNA repair machinery insert the correct bases during the editing process
This metabolic approach enabled researchers to create disease-relevant mutations that were previously too inefficient to generate reliably
๐ฑ Gene editing reaches woody plants through direct delivery to growing tips
Researchers successfully edited genes in citrus and poplar trees by shooting CRISPR proteins directly into actively growing stem tips using particle bombardment
This approach bypassed the need for lengthy tissue culture processes that often fail in woody plants, generating edited plants more efficiently
The method produced some plants with mixed edited and unedited cells, but provides a pathway for creating transgene-free edited trees
๐ฆ CRISPR gene drives show minimal mutation burden in safety study
A comprehensive mutation analysis in yeast found that CRISPR gene drives increased genome-wide mutation rates by less than 30%โmuch less than natural variation between organisms
The study tracked thousands of generations to measure unintended DNA changes and loss-of-heterozygosity events that could harm wild populations
Statistical analysis showed the mutation burden was so low it was barely detectable above background levels
๐ CRISPR screening reveals new drug target for liver cancer resistance
Genome-wide CRISPR screening identified ATOX1 as a key gene that helps liver cancer cells survive cisplatin chemotherapy
Researchers developed compound 8, which binds to ATOX1 protein with 12.5 ฮผM affinity and shows synergistic effects when combined with cisplatin
The compound works by disrupting copper metabolism and activating DNA methylation pathways that make cancer cells more sensitive to treatment
Implications
These studies showcase CRISPR's evolution from a research tool to a therapeutic platform, with successful treatments now working in living brains and new engineering approaches making gene editing more precise and accessible. The combination of improved delivery methods, enhanced editing tools, and better understanding of cellular metabolism is rapidly expanding what genetic diseases might be treatable.
Studies in this issue
Primary sources used for this newsletter.
- Using gene editing on Chd3 to improve behavior problems in living micemain storyNature2026-02-18PMID 41708849
- Stopping PKCฮฑ Activation with Gene Editing May Improve Heart Failurekey findingCirculation research2026-02-20PMID 41717698
- CRISPR screen finds how ATOX1 causes cisplatin resistance in liver cancer and tests drugs targeting itkey findingCommunications biology2026-02-16PMID 41699288
- Using nucleotide metabolism to influence base editing by glycosylase enzymeskey findingTheranostics2026-02-16PMID 41695474
- Genetic editing without added genes in citrus and poplar growing tissues using direct CRISPR-Cas9 protein deliverykey findingPlant cell reports2026-02-17PMID 41703314
- Maximum mutation load caused by a CRISPR-Cas9 gene drive elementkey findingG3 (Bethesda, Md.)2026-02-18PMID 41706533
- Improved Un1Cas12f1 tool for editing multiple genes at once with better efficiency and rangekey findingNature communications2026-02-18PMID 41708664
Continue reading
All CRISPR Gene Editing issuesGet the next CRISPR Gene Editing issue
Seven papers, once a week. Free.